CVE-2026-84458: critical vulnerability in zammad
Zammad: Account takeover via unverified email matching during SSO auto-link
Published
E-mail alert when it lands in KEV, gets a public PoC or its score goes up.
28Vexday Risk Score
No sign of exploitation. No public exploitation artifact known so far.
ssvc Trackcvss 9.1epss 0.4%
Zammad is a web based open source helpdesk/customer support system. Prior to 7.1.2, when the "Automatic account link on initial logon" setting is enabled, Zammad binds an incoming third-party (SSO) identity to an existing local account by matching the email address the identity provider reports, without verifying that the provider actually confirmed ownership of that email. An attacker who controls any identity at a configured provider, including, by default, any Azure AD tenant via Zammad's multi-tenant Microsoft 365 /common app registration, can set that identity's email to a victim's address, authenticate, and be logged in as the victim. This bypasses the victim's local password entirely and affects any existing account, including agents and administrators. Zammad will honor the xms_edov ID token claim when email verification is required in the Microsoft 365 setting, treating a missing claim as unverified. This issue is fixed in version 7.1.2.
CVSS:4.0/AV:N/AC:L/AT:P/PR:N/UI:N/VC:H/VI:H/VA:N/SC:N/SI:N/SA:N
Affected products
zammad · zammadRelated CVEs — zammad
In the same product, most dangerous first.
CVE-2026-63006MEDIUMZammad: HTML sanitizer API path allowlist bypass via interior path traversal in img src/srcsetEPSS 0.5%CVE-2026-34723HIGHZammad has incorrect access control in getting_started_controllerEPSS 0.5%CVE-2026-56735MEDIUMZammad: Improper neutralization of `srcset` attribute in IMG tags in ZammadEPSS 0.4%CVE-2026-56725HIGHZammad: Denial of Service via OTRS Import ControllerEPSS 0.4%CVE-2026-56734MEDIUMZammad: Avatar Image URL Server-Side Request ForwardingEPSS 0.4%CVE-2026-56729LOWZammad: Titles of knowledge base answers will be shown across all categories via the global searchEPSS 0.4%